Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

xylem inc. - XYL

XYL

Close Chg Chg %
128.57 -5.14 -4.00%

Pre-Market

123.43

-5.14 (4.00%)

Volume: 2.27M

Last Updated:

Dec 11, 2024, 3:59 PM EDT

Trade Now

Company Overview: xylem inc. - XYL

XYL Key Data

Open

$128.94

 Day Range

123.08 - 129.14

52 Week Range

106.52 - 146.08

 Market Cap

$31.24B

Shares Outstanding

242.95M

 Public Float

241.34M

Beta

1.05

 Rev. Per Employee

N/A

P/E Ratio

37.62

 EPS

$3.43

Yield

112.00%

 Dividend

$0.36

EX-DIVIDEND DATE

Nov 26, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.73M

  

XYL Performance

1 Week
 
 -2.37%
 
1 Month
 
 1.31%
 
3 Months
 
 -5.69%
 
1 Year
 
 11.43%
 
5 Years
 
 58.75%
 

XYL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 23
Full Ratings ➔

About xylem inc. - XYL

Xylem, Inc. engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water. The Applied Water segment encompasses the uses of water and focuses on the commercial, residential, and industrial end markets. The Measurement and Control Solutions segment focuses on developing technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The company was founded in 2011 and is headquartered in Washington, DC.

XYL At a Glance

Xylem, Inc.
301 Water Street SE
Washington, District of Columbia 20003
Phone 1-202-869-9150 Revenue 7.37B
Industry Industrial Machinery Net Income 609.00M
Sector Producer Manufacturing 2023 Sales Growth 32.954%
Fiscal Year-end 12 / 2024 Employees 23,000
View SEC Filings

XYL Valuation

P/E Current 37.617
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 40.97
Price to Sales Ratio 3.387
Price to Book Ratio 2.717
Price to Cash Flow Ratio 29.81
Enterprise Value to EBITDA 22.719
Enterprise Value to Sales 3.611
Total Debt to Enterprise Value 0.10

XYL Efficiency

Revenue/Employee 320,304.348
Income Per Employee 26,478.261
Receivables Turnover 4.556
Total Asset Turnover 0.612

XYL Liquidity

Current Ratio 1.761
Quick Ratio 1.30
Cash Ratio 0.462

XYL Profitability

Gross Margin 36.976
Operating Margin 9.977
Pretax Margin 8.62
Net Margin 8.267
Return on Assets 5.062
Return on Equity 8.917
Return on Total Capital 4.747
Return on Invested Capital 6.645

XYL Capital Structure

Total Debt to Total Equity 26.185
Total Debt to Total Capital 20.751
Total Debt to Total Assets 16.522
Long-Term Debt to Equity 24.985
Long-Term Debt to Total Capital 19.80
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Xylem Inc. - XYL

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
4.87B 5.20B 5.54B 7.37B
Sales Growth
-7.31% +6.71% +6.58% +32.95%
Cost of Goods Sold (COGS) incl D&A
3.04B 3.22B 3.44B 4.64B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
251.00M 245.00M 236.00M 436.00M
Depreciation
117.00M 118.00M 111.00M 193.00M
Amortization of Intangibles
134.00M 127.00M 125.00M 243.00M
COGS Growth
-4.78% +5.75% +6.71% +35.13%
Gross Income
1.83B 1.98B 2.10B 2.72B
Gross Income Growth
-11.22% +8.32% +6.37% +29.41%
Gross Profit Margin
+37.50% +38.07% +37.99% +36.98%
2020 2021 2022 2023 5-year trend
SG&A Expense
1.33B 1.38B 1.44B 1.99B
Research & Development
187.00M 204.00M 206.00M 232.00M
Other SG&A
1.14B 1.18B 1.23B 1.76B
SGA Growth
-1.41% +3.98% +4.12% +38.13%
Other Operating Expense
- - - -
-
Unusual Expense
114.00M (14.00M) 140.00M 46.00M
EBIT after Unusual Expense
383.00M 610.00M 525.00M 689.00M
Non Operating Income/Expense
(2.00M) (2.00M) (6.00M) 25.00M
Non-Operating Interest Income
7.00M 7.00M 16.00M 28.00M
Equity in Earnings of Affiliates
- - 2.00M 9.00M
-
Interest Expense
96.00M 97.00M 79.00M 79.00M
Interest Expense Growth
- +15.66% +1.04% -18.56%
Gross Interest Expense
96.00M 97.00M 79.00M 79.00M
Interest Capitalized
- - - -
-
Pretax Income
285.00M 511.00M 440.00M 635.00M
Pretax Income Growth
-31.49% +79.30% -13.89% +44.32%
Pretax Margin
+5.85% +9.83% +7.94% +8.62%
Income Tax
31.00M 84.00M 85.00M 26.00M
Income Tax - Current - Domestic
29.00M 21.00M 93.00M 19.00M
Income Tax - Current - Foreign
33.00M 53.00M 56.00M 86.00M
Income Tax - Deferred - Domestic
(29.00M) (2.00M) (55.00M) (57.00M)
Income Tax - Deferred - Foreign
(2.00M) 12.00M (9.00M) (22.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - 2.00M 9.00M
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
254.00M 427.00M 355.00M 609.00M
Minority Interest Expense
- - - -
-
Net Income
254.00M 427.00M 355.00M 609.00M
Net Income Growth
-36.66% +68.11% -16.86% +71.55%
Net Margin Growth
+5.21% +8.21% +6.41% +8.27%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
254.00M 427.00M 355.00M 609.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
254.00M 427.00M 355.00M 609.00M
EPS (Basic)
1.4102 2.369 1.9698 2.8063
EPS (Basic) Growth
-36.70% +67.99% -16.85% +42.47%
Basic Shares Outstanding
180.12M 180.25M 180.22M 217.01M
EPS (Diluted)
1.4026 2.3523 1.9616 2.7913
EPS (Diluted) Growth
-36.62% +67.71% -16.61% +42.30%
Diluted Shares Outstanding
181.10M 181.53M 180.98M 218.18M
EBITDA
748.00M 841.00M 901.00M 1.17B
EBITDA Growth
-22.57% +12.43% +7.13% +29.97%
EBITDA Margin
+15.35% +16.18% +16.26% +15.90%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 151.733
Number of Ratings 23 Current Quarters Estimate 1.13
FY Report Date 12 / 2024 Current Year's Estimate 4.23
Last Quarter’s Earnings 1.11 Median PE on CY Estimate N/A
Year Ago Earnings 3.78 Next Fiscal Year Estimate 4.744
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 13 18 18
Mean Estimate 1.13 1.02 4.23 4.74
High Estimates 1.15 1.11 4.25 4.94
Low Estimate 1.12 0.96 4.21 4.60
Coefficient of Variance 0.81 3.95 0.26 2.14

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 13 12 12
OVERWEIGHT 3 3 1
HOLD 6 7 7
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Xylem Inc. - XYL

Date Name Shares Transaction Value
Jun 12, 2024 Geri McShane VP, Controller & CAO 5,067 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $75.18 per share 380,937.06
Jun 12, 2024 Geri McShane VP, Controller & CAO 5,814 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $74.07 per share 430,642.98
Jun 12, 2024 Geri McShane VP, Controller & CAO 3,536 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $138.63 per share 490,195.68
Jun 12, 2024 Geri McShane VP, Controller & CAO 747 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 12, 2024 Geri McShane VP, Controller & CAO 1,019 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 7, 2024 Rodney O. Aulick SVP & President, WSS 21,800 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 7, 2024 Rodney O. Aulick SVP & President, WSS 76,287 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $139.01 per share 10,604,655.87
Jun 7, 2024 Rodney O. Aulick SVP & President, WSS 98,087 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $49.23 per share 4,828,823.01
Jun 5, 2024 Claudia S. Toussaint SVP, CPSO 4,204 Bona fide gift 0.00
May 21, 2024 Jeanne M. Beliveau-Dunn Director 8,454 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Lisa Glatch Director 8,755 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Earl R. Ellis Director 2,988 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Uday Yadav Director 7,326 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Lila Alexey Tretikov Director 7,380 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Mark D. Morelli Director 4,974 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Jerome A. Peribere Director 4,570 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Victoria Dux Harker Director 21,835 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Robert F. Friel Director 33,926 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Claudia S. Toussaint SVP, CPSO 6,488 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $127.94 per share 830,074.72
Mar 6, 2024 Claudia S. Toussaint SVP, CPSO 7,543 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $127.94 per share 965,051.42

Xylem Inc. in the News